These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 38705555)

  • 1. The neuroprotective effect of Diosgenin in the rat Valproic acid model of autism.
    Reza Naghdi M; Ahadi R; Motamed Nezhad A; Sadat Ahmadi Tabatabaei F; Soleimani M; Hajisoltani R
    Brain Res; 2024 Sep; 1838():148963. PubMed ID: 38705555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
    Mirza R; Sharma B
    Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of prenatal versus postnatal valproic acid rat models of autism: A behavioral and neurobiological study.
    Elnahas EM; Abuelezz SA; Mohamad MI; Nabil MM; Abdelraouf SM; Bahaa N; Hassan GA; Ibrahim EA; Ahmed AI; Aboul-Fotouh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110185. PubMed ID: 33238165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of early handling on anxiety-like behaviors of rats exposed to valproic acid pre-and post-natally.
    Shafaghi A; Vakili Shahrbabaki SS; Aminzadeh A; Heidari MR; Shamsi Meymandi M; Bashiri H
    Neurotoxicol Teratol; 2022; 89():107050. PubMed ID: 34801733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effect of the standardised extract of Bacopa monnieri (BacoMind) in valproic acid model of autism spectrum disorder in rats.
    Abhishek M; Rubal S; Rohit K; Rupa J; Phulen S; Gurjeet K; Raj SA; Manisha P; Alka B; Ramprasad P; Bikash M
    J Ethnopharmacol; 2022 Jul; 293():115199. PubMed ID: 35346813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin A supplementation ameliorates prenatal valproic acid-induced autism-like behaviors in rats.
    Liu Z; Wang J; Xu Q; Wu Z; You L; Hong Q; Zhu J; Chi X
    Neurotoxicology; 2022 Jul; 91():155-165. PubMed ID: 35594946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder.
    Luhach K; Kulkarni GT; Singh VP; Sharma B
    J Pharm Pharmacol; 2021 Oct; 73(11):1460-1469. PubMed ID: 34459916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of pioglitazone, a selective peroxisome proliferator-activated receptor-γ agonist in prenatal valproic acid-induced behavioral and biochemical autistic like features in Wistar rats.
    Mirza R; Sharma B
    Int J Dev Neurosci; 2019 Aug; 76():6-16. PubMed ID: 31128204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of behavioral, morphological and electrophysiological changes in prenatal and postnatal valproate induced rat models of autism spectrum disorder.
    Fereshetyan K; Chavushyan V; Danielyan M; Yenkoyan K
    Sci Rep; 2021 Dec; 11(1):23471. PubMed ID: 34873263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The histamine H3R antagonist DL77 attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism.
    Eissa N; Jayaprakash P; Azimullah S; Ojha SK; Al-Houqani M; Jalal FY; Łażewska D; Kieć-Kononowicz K; Sadek B
    Sci Rep; 2018 Aug; 8(1):13077. PubMed ID: 30166610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prangos ferulacea (L.) ameliorates behavioral alterations, hippocampal oxidative stress markers, and apoptotic deficits in a rat model of autism induced by valproic acid.
    Saadat M; Taherian AA; Aldaghi MR; Raise-Abdullahi P; Sameni HR; Vafaei AA
    Brain Behav; 2023 Nov; 13(11):e3224. PubMed ID: 37596045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the ERK1/2 Phosphorylation by Dextromethorphan Protects against Core Autistic Symptoms in VPA Induced Autistic Rats:
    Singla R; Mishra A; Joshi R; Kumar R; Sarma P; Sharma AR; Kaur G; Bhatia A; Medhi B
    ACS Chem Neurosci; 2021 May; 12(10):1749-1767. PubMed ID: 33913688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal spatiotemporal expression pattern of progranulin and neurodevelopment impairment in VPA-induced ASD rat model.
    Lan J; Hu Y; Wang X; Zheng W; Liao A; Wang S; Li Y; Wang Y; Yang F; Chen D
    Neuropharmacology; 2021 Sep; 196():108689. PubMed ID: 34175324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits of agomelatine in behavioral, neurochemical and blood brain barrier alterations in prenatal valproic acid induced autism spectrum disorder.
    Kumar H; Sharma BM; Sharma B
    Neurochem Int; 2015 Dec; 91():34-45. PubMed ID: 26498253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel potential of metformin on valproic acid-induced autism spectrum disorder in rats: involvement of antioxidant defence system.
    Ishola IO; Balogun AO; Adeyemi OO
    Fundam Clin Pharmacol; 2020 Dec; 34(6):650-661. PubMed ID: 32415700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effect of atorvastatin and risperidone on modulation of TLR4/NF-κB/NOX-2 in a rat model of valproic acid-induced autism.
    Farrag EAE; Askar MH; Abdallah Z; Mahmoud SM; Abdulhai EA; Abdelrazik E; Nashar EME; Alasiri FM; Alqahtani ANS; Eldesoqui M; Eldib AM; Magdy A
    Behav Brain Funct; 2024 Sep; 20(1):26. PubMed ID: 39350139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ameliorating effect of pioglitazone on prenatal valproic acid-induced behavioral and neurobiological abnormalities in autism spectrum disorder in rats.
    Sandhu A; Rawat K; Gautam V; Bhatia A; Grover S; Saini L; Saha L
    Pharmacol Biochem Behav; 2024 Apr; 237():173721. PubMed ID: 38307465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-aminolevulinic acid inhibits oxidative stress and ameliorates autistic-like behaviors in prenatal valproic acid-exposed rats.
    Matsuo K; Yabuki Y; Fukunaga K
    Neuropharmacology; 2020 May; 168():107975. PubMed ID: 31991146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inhibition of astrocytic aquaporin-4 induces autistic-like behavior in control rat offspring similar to maternal exposure to valproic acid.
    Davoudi S; Rahdar M; Hosseinmardi N; Behzadi G; Janahmadi M
    Physiol Behav; 2023 Oct; 269():114286. PubMed ID: 37402416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TCHis mitigate oxidative stress and improve abnormal behavior in a prenatal valproic acid-exposed rat model of autism.
    Jian J; Li LG; Zhao PJ; Zheng RJ; Dong XW; Zhao YH; Yin BQ; Cheng H; Li HL; Li EY
    Physiol Genomics; 2022 Sep; 54(9):325-336. PubMed ID: 35723222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.